Reduced expression of BTBD10, an Akt activator, leads to motor neuron death

Cell Death and Differentiation

Volumn 19, Issue 8, 2012, Pages 1398-1407

  Nawa, M ^a   Kage Nakadai, E ^b,c   Aiso, S ^d   Okamoto, K ^e   Mitani, S ^b,c   Matsuoka, M ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ALS; Caenorhabditis elegans; FUS; motor neuron death; TDP 43

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; ENZYME ACTIVATOR; PROTEIN BTBD10; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAENORHABDITIS ELEGANS; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; GENE DISRUPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MOTONEURON; MOTOR NEURON DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPINAL CORD;

ANIMALS; CAENORHABDITIS ELEGANS; CELL DEATH; GENE SILENCING; HEK293 CELLS; HELA CELLS; HUMANS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT;

CAENORHABDITIS ELEGANS; MUS MUSCULUS;

EID: 84863725199     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2012.19     Document Type: Article

References (39)

1. Franke TF. PI3K/Akt: getting it right matters. Oncogene 2008; 27: 6473-6488.
2. Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K et al. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol 2004; 24: 8778-8789. (Pubitemid 39245095)
3. Nawa M, Kanekura K, Hashimoto Y, Aiso S, Matsuoka M. A novel Akt/PKB-interacting protein promotes cell adhesion and inhibits familial amyotrophic lateral sclerosis-linked mutant SOD1-induced neuronal death via inhibition of PP2A-mediated dephosphorylation of Akt/PKB. Cell Signal 2008; 20: 493-505.
4. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009; 65 (Suppl 1): S3-S9.
5. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 2006; 7: 710-723. (Pubitemid 44267495)
6. Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001; 29: 166-173. (Pubitemid 32952653)
7. Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001; 29: 160-165. (Pubitemid 32952652)
8. Hadano S, Otomo A, Kunita R, Suzuki-Utsunomiya K, Akatsuka A, Koike M et al. Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking. PLoS One 2010; 5: e9805.
9. Kanekura K, Hashimoto Y, Niikura T, Aiso S, Matsuoka M, Nishimoto I. Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants. J Biol Chem 2004; 279: 19247-19256. (Pubitemid 38623356)
10. Kanekura K, Hashimoto Y, Kita Y, Sasabe J, Aiso S, Nishimoto I et al. A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutantinduced motoneuronal cell death. J Biol Chem 2005; 280: 4532-4543. (Pubitemid 40288621)
11. Wang X, Liu Y, Yang Z, Zhang Z, Zhou W, Ye Z et al. Glucose metabolism-related protein 1 (GMRP1) regulates pancreatic beta cell proliferation and apoptosis via activation of Akt signalling pathway in rats and mice. Diabetologia 2011; 54: 852-863.
12. Wang J, Farr GW, Hall DH, Li F, Furtak K, Dreier L et al. An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet 2009; 5: e1000350.
13. Liachko NF, Guthrie CR, Kraemer BC. Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. J Neurosci 2010; 30: 16208-16219.
14. Murakami T, Yang SP, Xie L, Kawano T, Fu D, Mukai A et al. ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism. Hum Mol Genet 2012; 21: 1-9.
15. Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 2010; 19: R46-R64.
16. Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, Ajroud K et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 2010; 67: 739-748.
17. Royal DC, Bianchi L, Royal MA, Lizzio Jr M, Mukherjee G, Nunez YO et al. Temperaturesensitive mutant of the Caenorhabditis elegans neurotoxic MEC-4(d) DEG/ENaC channel identifies a site required for trafficking or surface maintenance. J Biol Chem 2005; 280: 41976-41986. (Pubitemid 43023166)
18. Darland-Ransom M, Wang X, Sun CL, Mapes J, Gengyo-Ando K, Mitani S et al. Role of C. elegans TAT-1 protein in maintaining plasma membrane phosphatidylserine asymmetry. Science 2008; 320: 528-531. (Pubitemid 351590665)
19. Gumienny TL, Lambie E, Hartwieg E, Horvitz HR, Hengartner MO. Genetic control of programmed cell death in the Caenorhabditis elegans hermaphrodite germline. Development 1999; 126: 1011-1022. (Pubitemid 29142008)
20. Quevedo C, Kaplan DR, Derry WB. AKT-1 regulates DNA-damage-induced germline apoptosis in C. elegans. Curr Biol 2007; 17: 286-292. (Pubitemid 46186027)
21. Nash B, Calarita A, Zheng H, Roy PJ, Culotti JG. The Forkhead transcription factor UNC-130 is required for the graded spatial expression of the UNC-129 TGF-b guidance factor in C. elegans. Genes Dev 2000; 14: 2486-2500.
22. Huang X, Cheng HJ, Tessier-Lavigne, Jim Y. MAX-1, a novel PH/MyTH4/FERM domain cytoplasmic protein implicated in netrin-mediated axon repulsion. Neuron 2002; 34: 563-576. (Pubitemid 34628753)
23. Bany IA, Dong MQ, Koelle MR. Genetic and cellular basis for acetylcholine inhibition of Caenorhabditis elegans egg-laying behavior. J Neurosci 2003; 23: 8060-8069. (Pubitemid 37082459)
24. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994; 264: 1772-1775. (Pubitemid 24227760)
25. Chiba T, Hashimoto Y, Tajima H, Yamada M, Kato R, Niikura T et al. Neuroprotective effect of activity-dependent neurotrophic factor against toxicity from familial amyotrophic lateral sclerosis-linked mutant SOD1 in vitro and in vivo. J Neurosci Res 2004; 78: 542-552. (Pubitemid 39536498)
26. Dewil M, Lambrechts D, Sciot R, Shaw PJ, Ince PG, Robberecht Wet al. Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 2007; 33: 499-509. (Pubitemid 47390084)
27. Tolosa L, Mir M, Olmos G, Lladó J. Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition. Neuroscience 2009; 158: 1348-1355.
28. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004; 429: 413-417. (Pubitemid 38715132)
29. Kieran D, Sebastia J, Greenway MJ, King MA, Connaughton D, Concannon CG et al. Control of motoneuron survival by angiogenin. J Neurosci 2008; 28: 14056-14061.
30. Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 2010; 107: 3858-3863.
31. Huang C, Zhou H, Tong J, Chen H, Liu YJ, Wang D et al. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. PLoS Genet 2011; 7: e1002011.
32. Peviani M, Cheroni C, Troglio F, Quarto M, Pelicci G, Bendotti C. Lack of changes in the PI3K/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 2007; 34: 592-602. (Pubitemid 46483084)
33. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 2002; 99: 5515-5520. (Pubitemid 34411580)
34. Tsuji K, Mizumoto K, Yamochi T, Nishimoto I, Matsuoka M. Differential effect of ik3-1/cables on p53-and p73-induced cell death. J Biol Chem 2002; 277: 2951-2957. (Pubitemid 34953330)
35. Brenner S. The genetics of Canorhabditis elegans. Genetics 1974; 77: 71-94.
36. Gengyo-Ando K, Mitani S. Characterization of mutations induced by ethyl methanesulfonate, UV, and trimethylpsoralen in the nematode Caenorhabditis elegans. Biochem Biophys Res Commun 2000; 269: 64-69. (Pubitemid 30440255)
37. Mello CC, Kramer JM, Stinchcomb D, Ambros V. Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J 1991; 10: 3959-3970. (Pubitemid 21905425)
38. Lee H, Cho JS, Lambacher N, Lee J, Lee SJ, Lee TH et al. The Caenorhabditis elegans AMP-activated protein kinase AAK-2 is phosphorylated by LKB1 and is required for resistance to oxidative stress and for normal motility and foraging behavior. J Biol Chem 2008; 283: 14988-14993.
39. Chiba T, Yamada M, Hashimoto Y, Sato M, Sasabe J, Kita Y et al. Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo. J Neurosci 2005; 25: 10252-10261. (Pubitemid 41636222)